Increasingly, biopharma companies are turning to outsource providers for services including both non-clinical and clinical activities through final product manufacturing. For small companies, outsourcing decisions can become strategic drivers of business value and the achievement of a successful exit. Therefore, choosing the best contract services providers and developing successful programs are critical management challenges.

This program will feature a panel of industry experts, including the BioPark's Marco Chacon, who will share best practices and real life practical experiences with outsourcing and describe key ingredients that are necessary to find a suitable CRO. Our speakers will address issues related to what and when to outsource, how to establish an effective outsource program, avoid pitfalls, decrease risk, and drive the business value proposition.

Our panelists include:

Joseph Amprey, III, MD, Ph.D. (invited)
Chief Business Officer and Co-Founder
Zyngenia, Inc.

Marco Chacón,Ph.D.
Founder, CEO and President
Paragon Bioservices, Inc.

Michael Richman
President and CEO
Amplimmune, Inc.

Amita Shukla
Principal
New Enterprise Associates

Christine Warrington
Head of Global Sales and Marketing
Manager Sales, North America
Cato Research

(Registration and networking from 7:30 – 8:15am; the program will begin at 8:30am)

Series Sponsors: Accelovance, Cylex, DVC, Martek, VWR, Adventist Healthcare, GenVec, JHU Center for Biotechnology Education, MedImmune, RegeneRx, PhRMA

Supported in part by a grant from Maryland's Department of Business and Economic Development.